Randox Biochip is centre stage at Goodwood Festival of Speed Future Lab

You visit the doctor because you think there is a problem. The doctor suspects it may be an infection but she’s not sure. A blood sample is taken and sent to the laboratory where three to five tests are run on it. Your blood does not show a positive reading for any of the tests conducted. You still don’t know what’s wrong.  Does this sound familiar?

Enter a pioneering piece of technology called the Biochip. This health testing platform, from global diagnostics company Randox, and on show at this year’s Goodwood Festival of Speed, can uniquely run multiple tests simultaneously – making sure you get the right diagnosis as fast as possible.

Current and futuristic developments in this critical strand of medicine, involving detailed analysis of blood to identify both current and future health risks, appeared as part of the Future Lab project at the festival which took place  8th – 11th July 2021. Those who visited Future Lab found out how technology can be utilised to improve the speed and accuracy of health diagnoses across the world.

The event’s reach afforded Randox a valuable platform from which to promote the importance of early, accurate and reliable diagnostics, and understandably, our message this year resonates more clearly than ever before.

The impact of the pandemic has highlighted the need for early and accurate diagnostics, which can and do save lives. Randox set up the largest throughput COVID-19 laboratory in the UK and we have completed over 12 million gold-standard PCR tests for the UK’s National Testing Programme, representing approximately 21% of all PCR tests in the UK.

More sensitive, comprehensive and accurate technologies hold the promise of much earlier and more effective diagnosis, often before symptoms appear – greatly improving healthcare outcomes and reducing the burden on healthcare services.  And these technologies are directly available to the individual through Randox Health, not just through GPs or hospitals.

It is also a fact that diagnostics have historically been undervalued – in healthcare systems around the world laboratory technologies account for around 2% of overall budgets, yet 70%-80% of all healthcare decisions affecting diagnosis or treatment involve a laboratory investigation.

Sensing the potential to improve healthcare through diagnostic innovation, Randox has invested significantly in the development of Biochip Array Technology, allowing many tests to be run simultaneously.

The Randox Biochip is key to unlocking true personalised medicine. Ultimately it acts as a roadmap of your health by predicting the health conditions of which you are personally at risk in the future. By taking preventive action you will be empowered to live healthier for longer. It’s the world’s first technology of its kind, capable of extending your life.

Also new to the Goodwood Festival of Speed this year was the Future Lab Podcast, presented by Randox.

Over the course of the podcast series, Future Lab curator Lucy Johnston met the people tackling the biggest problems facing planet earth and pushing humanity to achieve things we’ve never seen before. The Future Lab podcast tells the stories of the people taking ideas from the pages of science fiction and bringing them to life before our eyes.⠀⠀

Listen here.

For press enquiries please contact Amy Millar in the Randox PR team on amy.millar@randox.com or 028 9442 2413

 

Related Pages